Stock Market
Today's Market: Stocks End Weak Session Mixed; Tech Fares the Worst
| Jump to Sections Below | |
was saved by a couple of outperformers, sectors that have been strong of late weren't, and weak sectors, including technology, were. It was the kind of day that investors like to explain away as a product of listless August meandering, but that's a less convincing argument for those who have watched several months of failed rallies and hopelessly range-bound action.
| |||||||||||||||||||||||||||||||||||||||||||||
lost 12.62, or 0.9%, to 1460.25, today, while the Dow gained 2.93 to 10,908.76. The Russell 2000
fell 5.85, or 1.15%, to 501.65. Technology shares came under pressure, as a reasonably strong earnings report from Applied Materials (AMAT) couldn't lift the chip stocks. Applied Materials lost 4% and the Philadelphia Stock Exchange Semiconductor Index fell 2.2%. That, and losses in big-cap stocks and telecommunications names, caused the Nasdaq Composite Index
to drop 93.51, or 2.4%, to 3759.99, ending the session near the day's lows. TheStreet.com Internet Sector index lost 14.72, or 2%, to 729.58. "AMAT can come out with numbers, and it doesn't spark a rally in that space," said Rob Cummisford, portfolio manager at Kent Funds in Grand Rapids, Mich. "People have decided the semiconductor cycle is coming to an end, with Nokia (NOK) announcing slower growth." Indeed, earnings reports aren't serving as a catalyst for this market anymore. Investors may not get their hopes up that PC-maker Dell's(DELL) post-close earnings will help the market tomorrow. Dell reported earnings of 22 cents a share, beating estimates by a penny. And the market's confusion, that is, whether to invest in growth or defensive stocks, had resulted in several months of jockeying between pharmaceuticals and technology. Now, with Eli Lilly (LLY) potentially losing patent protection of Prozac, one of the market's defensive supports has been cut down at the knees. The drug stocks, destroyed yesterday after Lilly lost a court battle intended to protect the company's Prozac patent, were better today, but not by much. TheStreet.com wrote about this yesterday. The Amex Pharmaceutical Index lost nearly 6% yesterday, and gained 1% today. Johnson & Johnson (JNJ) rose 2.8%, however. And retailers had a terrible day, as the S&P Retail Index ended down sharply, losing 3.4%, due to a 14.3% drop in Gap and a 4% loss in Wal-Mart (WMT). The negative action in retailers serves as a bit of a reminder that the much hoped-for "soft landing" scenario that the market is looking for may have some bumps and bruises along the way -- and if a forceful slowdown in consumer demands is going to be engineered, it's the retailers on the front lines. Absent the intermittent strength in retailers and drugs that had provided some ballast to this constantly vacillating market, only financials and utilities remained as prominent leaders, and even they suffered today. "The old economy is getting a little money, but the utilities had a great run, financials had a great run, and retailers are taking it on the chin ... it's a real mixed marketplace," said Bob Basel, director of listed trading at Salomon Smith Barney. "We're having trouble picking it up from here." The banks were mixed today. The Philadelphia Stock Exchange/KBW Bank Index ended off 0.4%, while the S&P Insurance Index lost 1.3%. The Dow Jones Utility Index dropped 0.5%. Fed Out of the Way... Doesn't Help Tech
The market's convinced now that the Federal Reserve
won't be tightening rates on Aug. 22, the Fed's next meeting, and that's a nice, underlying cushion preventing the market from falling significantly. But positive developments have been limited. Basel said the market is incessantly waiting for a piece of data to act as a catalyst, when in this stagnant time, there's little an economic release can say that the market doesn't already know. "It's been waiting for data for a year," he said. "It's a day-by-day, data-by-data thing." Some big economic numbers are due out tomorrow, with the release of Market Internals
Breadth was negative on moderate volume. New York Stock Exchange
: 1,350 advancers, 1,473 decliners, 942 million shares. 82 new 52-week highs, 24 new lows. Nasdaq Stock Market
: 1,585 advancers, 2,377 decliners, 1.3 billion shares. 50 new highs, 117 new lows. Back to top Most Active Stocks
NYSE Most Actives- Gap (GPS): 38.2 million shares. Petrolo Brasilero SA (PBR): 36 million shares. Eli Lilly: 24.8 million shares.
- Cisco: 58.4 million shares. WorldCom (WCOM): 33 million shares. Applied Materials: 29.7 million shares.
Sector Watch
The American Stock Exchange Broker/Dealer Index dropped 1.7%. Stalwarts Lehman Brothers (LEH) and Merrill Lynch(MER) struck new intra-day trading highs, though both ended lower. Biotechnology stocks were whipped, with the Nasdaq Biotechnology Index ending 3.7% lower. High-flying momentum plays such as Protein Design Labs (PDLI) and Human Genome Sciences (HGSI) were slammed, each dropping 7.2%. With crude oil prices tipping over $30 per barrel, oil stocks were higher. The American Stock Exchange Oil & Gas Index rose 1.2%, and Dow component ExxonMobil(XOM) ended up 1.7%. "I think it's a combination of the API numbers and some political controversy," said Charles T. Maxwell, senior energy analyst at Weeden & Co., commenting on the pop in the price of crude oil after a report from the American Petroleum Institute. "The API numbers that came out on Wednesday indicated a drop in crude inventory in the U.S. And there's also some political maneuvering going on that is causing the prices to go up," Maxwell said. "Venezuela President Hugo Chavez is making a tour of OPEC capitals and will make a stop in Baghdad to meet with Saddam Hussein." All this is making waves in the United States because Venezuela is a member of the United Nations. The Philadelphia Stock Exchange Oil Services Index ended 0.9% lower. Back to topBonds/Economy
International
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |


Connect with TheStreet